SU

Srushti Umesh Dange

Active Director Director DIN 10933417
DIN 10933417 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value •••• Premium profile

About Srushti Umesh Dange

Data last updated:

Srushti Umesh Dange is a Director at Icon Drugs Private Limited (since 2025). The company operates in Pharma. Icon Drugs Private Limited reported revenue of ₹2.66 Cr (FY 2025).

DIN 10933417
Primary Designation Director
Industry Pharma
First Appointment 25 Jan 2025
Oldest Company Age 24 yrs
Largest company Icon Drugs Private Limited · ₹2.66 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Icon Drugs Private Limited U24231MH2002PTC134479
Director25 Jan 20252002₹2.66 Cr (FY 2025)Active

Board colleagues of Srushti Umesh Dange

Directorship timeline

Open interactive timeline →
Icon Drugs Private Limited
Premium access

Shareholding and investment profile for Srushti Umesh Dange

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srushti Umesh Dange

Srushti Umesh Dange currently holds 1 directorship: Icon Drugs Private Limited (Director, since 25 Jan 2025, revenue ₹2.66 Cr (FY 2025)).

Srushti Umesh Dange was first appointed on 25 Jan 2025 as Director at Icon Drugs Private Limited.

The current boards of Srushti Umesh Dange's companies include Rachana Umesh Dange (Icon Drugs Private Limited), Sushrut Umesh Dange (Icon Drugs Private Limited), Umesh Babanrao Dange (Icon Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available